Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case ‐control study
ConclusionsICHs during VKA therapy preferentially occur in very elderly patients. The risk of ICH is not predicted by the commonly used risk scores.
Source: Cardiovascular Therapeutics - Category: Cardiology Authors: Luca Zanella,
Giacomo Zoppellaro,
Lucia Marigo,
Gentian Denas,
Seena Padayattil Jose,
Vittorio Pengo Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Databases & Libraries | Heart | Statistics | Study | Thrombosis | Vitamin K | Vitamins